Chronic myeloid leukemia (CML) with P190(BCR-ABL): analysis of characteristics, outcomes, and prognostic significance

The most common BCR-ABL transcripts in chronic myeloid leukemia (CML) are e13a2(b2a2) and e14a2(b3a2). Other transcripts such as e1a2 are rare and their outcome with tyrosine kinase inhibitors (TKI) therapy is undefined. We analyzed 1292 CML patients and identified 14 with only e1a2 transcripts, 9 i...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood
Hlavní autoři: Verma, Dushyant, Kantarjian, Hagop M., Jones, Dan, Luthra, Rajyalakshmi, Borthakur, Gautam, Verstovsek, Srdan, Rios, Mary Beth, Cortes, Jorge
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2009
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4828071/
https://ncbi.nlm.nih.gov/pubmed/19531657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-02-204693
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky